← FMC overview

FMC vs Sociedad Quimica y Minera de Chile SA ADR B: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

FMC Corporation (FMC)

Q3 2026
▲3▼1

FMC cuts outlook on pricing, but debt cuts and new herbicide advance

  • Guidance cut on pricing pressure FMC lowered its 2026 revenue and profit outlook, blaming tough market conditions and falling prices for its crop chemicals. Full-year earnings per share are now expected to drop about 55% at the midpoint. Weaker profit expectations pull the stock down because investors pay for future earnings.

    The guidance cut is the main new negative force on FMC's price this period.

  • Debt reduction progress lifts shares FMC is raising about $1 billion to pay down debt: a $400 million investment from Tessenderlo for a 20% stake, a $200 million upfront payment from Corteva, and a $252 million sale of its India business. Less debt means less risk, which helped the beaten-down stock jump 15.8%.

    Debt reduction is the key positive force behind the period's sharp share rally.

  • New herbicide filed in Brazil FMC filed its rimisoxafen herbicide for approval in Brazil, a huge soybean and corn market, after a similar U.S. filing. It is the first herbicide with two ways of killing resistant weeds. Approval is uncertain and years away, but it supports future growth hopes.

    The Brazil filing is a new pipeline event that supports FMC's long-term growth story.

  • Tessenderlo backs FMC as cornerstone investor Tessenderlo Group, fresh off a strong first half, confirmed its $400 million investment in FMC and its role as a cornerstone investor. A healthy, committed backer strengthens confidence in FMC's balance sheet and turnaround plan, though Tessenderlo also faces its own cost and currency pressures.

    Tessenderlo's strong results reinforce confidence in its FMC investment, a positive capital signal.

September 2026
▲3▼1

FMC cuts outlook on pricing, but debt cuts and new herbicide advance

  • Guidance cut on pricing pressure FMC lowered its 2026 revenue and profit outlook, blaming tough market conditions and falling prices for its crop chemicals. Full-year earnings per share are now expected to drop about 55% at the midpoint. Weaker profit expectations pull the stock down because investors pay for future earnings.

    The guidance cut is the main new negative force on FMC's price this period.

  • Debt reduction progress lifts shares FMC is raising about $1 billion to pay down debt: a $400 million investment from Tessenderlo for a 20% stake, a $200 million upfront payment from Corteva, and a $252 million sale of its India business. Less debt means less risk, which helped the beaten-down stock jump 15.8%.

    Debt reduction is the key positive force behind the period's sharp share rally.

  • New herbicide filed in Brazil FMC filed its rimisoxafen herbicide for approval in Brazil, a huge soybean and corn market, after a similar U.S. filing. It is the first herbicide with two ways of killing resistant weeds. Approval is uncertain and years away, but it supports future growth hopes.

    The Brazil filing is a new pipeline event that supports FMC's long-term growth story.

  • Tessenderlo backs FMC as cornerstone investor Tessenderlo Group, fresh off a strong first half, confirmed its $400 million investment in FMC and its role as a cornerstone investor. A healthy, committed backer strengthens confidence in FMC's balance sheet and turnaround plan, though Tessenderlo also faces its own cost and currency pressures.

    Tessenderlo's strong results reinforce confidence in its FMC investment, a positive capital signal.

Latest
▲3▼1

FMC cuts outlook on pricing, but debt cuts and new herbicide advance

  • Guidance cut on pricing pressure FMC lowered its 2026 revenue and profit outlook, blaming tough market conditions and falling prices for its crop chemicals. Full-year earnings per share are now expected to drop about 55% at the midpoint. Weaker profit expectations pull the stock down because investors pay for future earnings.

    The guidance cut is the main new negative force on FMC's price this period.

  • Debt reduction progress lifts shares FMC is raising about $1 billion to pay down debt: a $400 million investment from Tessenderlo for a 20% stake, a $200 million upfront payment from Corteva, and a $252 million sale of its India business. Less debt means less risk, which helped the beaten-down stock jump 15.8%.

    Debt reduction is the key positive force behind the period's sharp share rally.

  • New herbicide filed in Brazil FMC filed its rimisoxafen herbicide for approval in Brazil, a huge soybean and corn market, after a similar U.S. filing. It is the first herbicide with two ways of killing resistant weeds. Approval is uncertain and years away, but it supports future growth hopes.

    The Brazil filing is a new pipeline event that supports FMC's long-term growth story.

  • Tessenderlo backs FMC as cornerstone investor Tessenderlo Group, fresh off a strong first half, confirmed its $400 million investment in FMC and its role as a cornerstone investor. A healthy, committed backer strengthens confidence in FMC's balance sheet and turnaround plan, though Tessenderlo also faces its own cost and currency pressures.

    Tessenderlo's strong results reinforce confidence in its FMC investment, a positive capital signal.

Sociedad Quimica y Minera de Chile SA ADR B (SQM)

Q3 2026
▲3▼1

SQM's profit surges on record lithium sales and higher prices

  • Record lithium sales and raised demand outlook SQM sold a record 84,000+ tonnes of lithium in Q2 and now expects global demand to exceed 2.1 million tonnes in 2026, up from 1.9 million. Stronger demand supports higher prices and volumes, directly lifting SQM's revenue and profit.

    This is the core new operational driver behind the earnings beat and future growth.

  • Blowout first-half earnings SQM's net income jumped 353.5% to $1.02 billion in H1 2026, with Q2 profit up 646% to $660 million. Revenue more than doubled. This huge profit beat shows the business is generating far more cash, which supports the stock price.

    The earnings result is the main new financial event that answers why the stock is moving.

  • Nova Andino JV targets 70% production boost SQM and Codelco's joint venture aims to raise Atacama lithium output to as much as 470,000 tonnes per year, up from about 270,000, as part of a $3 billion overhaul. This long-term growth plan increases future supply and revenue potential.

    It is a major new expansion plan that shapes SQM's long-term production and earnings power.

  • CATL supply surge pressures lithium prices CATL's Jianxiawo mine could add about 46,000 tonnes per year of lithium supply, roughly 3% of global supply, pushing Chinese lithium prices down 10% to a 10-week low. More supply can lower prices and hurt SQM's revenue per tonne.

    It is the main new counterweight that could cap lithium prices and SQM's upside.

July 2026
▲3▼1

SQM's profit surges on record lithium sales and higher prices

  • Record lithium sales and raised demand outlook SQM sold a record 84,000+ tonnes of lithium in Q2 and now expects global demand to exceed 2.1 million tonnes in 2026, up from 1.9 million. Stronger demand supports higher prices and volumes, directly lifting SQM's revenue and profit.

    This is the core new operational driver behind the earnings beat and future growth.

  • Blowout first-half earnings SQM's net income jumped 353.5% to $1.02 billion in H1 2026, with Q2 profit up 646% to $660 million. Revenue more than doubled. This huge profit beat shows the business is generating far more cash, which supports the stock price.

    The earnings result is the main new financial event that answers why the stock is moving.

  • Nova Andino JV targets 70% production boost SQM and Codelco's joint venture aims to raise Atacama lithium output to as much as 470,000 tonnes per year, up from about 270,000, as part of a $3 billion overhaul. This long-term growth plan increases future supply and revenue potential.

    It is a major new expansion plan that shapes SQM's long-term production and earnings power.

  • CATL supply surge pressures lithium prices CATL's Jianxiawo mine could add about 46,000 tonnes per year of lithium supply, roughly 3% of global supply, pushing Chinese lithium prices down 10% to a 10-week low. More supply can lower prices and hurt SQM's revenue per tonne.

    It is the main new counterweight that could cap lithium prices and SQM's upside.

Latest
▲3▼1

SQM's profit surges on record lithium sales and higher prices

  • Record lithium sales and raised demand outlook SQM sold a record 84,000+ tonnes of lithium in Q2 and now expects global demand to exceed 2.1 million tonnes in 2026, up from 1.9 million. Stronger demand supports higher prices and volumes, directly lifting SQM's revenue and profit.

    This is the core new operational driver behind the earnings beat and future growth.

  • Blowout first-half earnings SQM's net income jumped 353.5% to $1.02 billion in H1 2026, with Q2 profit up 646% to $660 million. Revenue more than doubled. This huge profit beat shows the business is generating far more cash, which supports the stock price.

    The earnings result is the main new financial event that answers why the stock is moving.

  • Nova Andino JV targets 70% production boost SQM and Codelco's joint venture aims to raise Atacama lithium output to as much as 470,000 tonnes per year, up from about 270,000, as part of a $3 billion overhaul. This long-term growth plan increases future supply and revenue potential.

    It is a major new expansion plan that shapes SQM's long-term production and earnings power.

  • CATL supply surge pressures lithium prices CATL's Jianxiawo mine could add about 46,000 tonnes per year of lithium supply, roughly 3% of global supply, pushing Chinese lithium prices down 10% to a 10-week low. More supply can lower prices and hurt SQM's revenue per tonne.

    It is the main new counterweight that could cap lithium prices and SQM's upside.